Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

Similar articles for PubMed (Select 24568516)

1.

Gemcitabine and Cisplatin followed by chemo-radiation for advanced nasopharyngeal carcinoma.

Jamshed A, Hussain R, Iqbal H.

Asian Pac J Cancer Prev. 2014;15(2):899-904.

2.
3.

A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma.

Lim AM, Corry J, Collins M, Peters L, Hicks RJ, D'Costa I, Coleman A, Chua M, Solomon B, Rischin D.

Oral Oncol. 2013 May;49(5):468-74. doi: 10.1016/j.oraloncology.2012.12.012. Epub 2013 Jan 29.

PMID:
23369852
4.

Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency.

Rosenblatt E, Abdel-Wahab M, El-Gantiry M, Elattar I, Bourque JM, Afiane M, Benjaafar N, Abubaker S, Chansilpa Y, Vikram B, Levendag P.

Radiat Oncol. 2014 Mar 1;9:67. doi: 10.1186/1748-717X-9-67.

5.

Gemcitabine-based induction chemotherapy and concurrent with radiation in advanced head and neck cancer.

El Deen DA, Toson EA, El Morsy SM.

Med Oncol. 2012 Dec;29(5):3367-73. doi: 10.1007/s12032-012-0269-x. Epub 2012 Jun 8.

PMID:
22678924
6.

[Concurrent chemoradiotherapy followed by adjuvant chemotherapy for stage III-IVa nasopharyngeal carcinoma].

Hu QY, Liu P, Wang L, Fu ZF.

Ai Zheng. 2007 Apr;26(4):394-7. Chinese.

PMID:
17430659
8.
9.

Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.

Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL.

J Clin Oncol. 2004 Aug 1;22(15):3061-9.

11.

Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.

Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, Liossi P, Giannakouras G, Douzinas EE, Katsilieris I.

Oral Oncol. 2006 Aug;42(7):675-84. Epub 2006 May 30.

PMID:
16731029
12.

Efficacy and feasibility of cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma.

Demizu Y, Sasaki R, Soejima T, Maruta T, Okamoto Y, Yamada K, Yoden E, Ejima Y, Ota Y, Ishida H, Nibu K, Sugimura K.

Jpn J Clin Oncol. 2006 Oct;36(10):620-5. Epub 2006 Aug 12.

13.

Glycididazole sodium combined with radiochemotherapy for locally advanced nasopharyngeal carcinoma.

Li MY, Liu JQ, Chen DP, Qi B, Liang YY, Yin WJ.

Asian Pac J Cancer Prev. 2014;15(6):2641-6.

14.

Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.

Al-Amro A, Al-Rajhi N, Khafaga Y, Memon M, Al-Hebshi A, El-Enbabi A, El-Husseiny G, Radawi A, Belal A, Allam A, El-Sebaie M.

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):508-13.

PMID:
15890594
15.

Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.

Koo DH, Park SI, Kim YH, Kim JH, Jung HY, Lee GH, Choi KD, Song HJ, Song HY, Shin JH, Cho KJ, Yoon DH, Kim SB.

Cancer Chemother Pharmacol. 2012 Mar;69(3):655-63. doi: 10.1007/s00280-011-1750-5. Epub 2011 Oct 4.

PMID:
21968953
17.

Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer - a retrospective single center analysis.

Saleh-Ebrahimi L, Zwicker F, Muenter MW, Bischof M, Lindel K, Debus J, Huber PE, Roeder F.

Radiat Oncol. 2013 Jan 24;8:20. doi: 10.1186/1748-717X-8-20.

18.

Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial.

Reni M, Balzano G, Aprile G, Cereda S, Passoni P, Zerbi A, Tronconi MC, Milandri C, Saletti P, Rognone A, Fugazza C, Magli A, Di Muzio N, Di Carlo V, Villa E.

Ann Surg Oncol. 2012 Jul;19(7):2256-63. doi: 10.1245/s10434-011-2205-2. Epub 2012 Jan 12.

PMID:
22237835
19.

Concurrent chemoradiotherapy with or without adjuvant chemotherapy in intermediate and locoregionally advanced nasopharyngeal carcinoma.

Zhang W, Dou H, Lam C, Liu J, Zhou J, Liu Y, Wang X.

Tumour Biol. 2013 Jun;34(3):1729-36. doi: 10.1007/s13277-013-0710-6. Epub 2013 Feb 23.

PMID:
23436047
20.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk